Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| AZI | Autozi Internet Technology (Global) | $3.86 | $0.84 | 27.82% | 18.7M | $309M | $1.33$69.00 |
| BEEM | Beam Global | $2.25 | $0.48 | 27.10% | 32.2M | $34M | $1.33$4.04 |
| BNAI | Brand Engagement Network | $4.47 | $0.86 | 23.82% | 744.3K | $16M | $1.18$10.50 |
| RZLT | Rezolute | $2.78 | $0.30 | 12.10% | 18.8K | $230M | $1.07$11.46 |
| TGTX | TG Therapeutics | $31.10 | $3.23 | 11.57% | 1.8M | $4.4B | $25.28$46.48 |
| CERS | Cerus | $2.81 | $0.29 | 11.51% | 621.6K | $484M | $1.12$2.82 |
| MSTP | GraniteShares ETF Trust - GraniteShares 2x Long Mstr Daily ETF | $3.84 | $0.36 | 10.28% | 125.3K | - | $2.69$32.23 |
| MSTX | Tidal Trust II - Defiance Daily Target 2x Long Mstr ETF | $5.31 | $0.46 | 9.48% | 9.3M | - | $3.73$64.40 |
| IQST | iQSTEL | $2.90 | $0.24 | 9.02% | 28.7K | $12M | $2.63$22.95 |
| MST | Tidal Trust II - Defiance Leveraged Long + Income Mstr ETF | $7.64 | $0.59 | 8.43% | 176.2K | - | $5.68$96.92 |
Related Articles
Featured Article
Citigroup Says This Obesity Drugmaker's Stock Is Now a Buy
James Brumley|Nov 5, 2025
The bank's lead analyst recognizes the importance of getting in early with potentially game-changing drug development.
Could This Anti-Obesity Drug Biotech Be Poised to Soar in 2026?
Prosper Junior Bakiny|Oct 29, 2025
This stock has caught fire after some recent events, but how long will that last?
BioAge Labs Stock Just Soared. Does It Have More Fuel to Climb Higher?
Cory Renauer|Oct 26, 2025
The clinical-stage biotech is working on a new type of weight management drug.
Advertisement
Interested in Weight Loss Stocks Besides Novo Nordisk and Eli Lilly? You Might Want To Check Out This New IPO Stock
Adam Spatacco|Oct 12, 2024
BioAge Labs is the latest pharmaceutical company looking to make waves in the weight loss realm.
3 Reasons to Buy BioAge Labs Stock Hand Over Fist in October
Alex Carchidi|Oct 5, 2024
There's a chance that its lead candidate could become one of the top drugs ever.
This IPO Biotech Stock Could Be the Next Eli Lilly
Alex Carchidi|Oct 3, 2024
BioAge has its eyes on a handful of truly gargantuan markets.
3 Top Biotech Stocks Defying the Bear Market
James Halley|Apr 25, 2023
All three companies have therapies with strong sales potential.
2 Real Estate Stocks to Avoid Like the Plague
Liz Brumer|Feb 18, 2022
These two stocks are headed in the wrong direction, and the risks far outweigh any potential reward.
Is This Cheap Cancer-Drug Company a Top Stock to Buy Now?
Zhiyuan Sun|Feb 19, 2021
Large biotechs are taking over small-cap companies (and their cancer treatments) left and right. Could this business be the next target?
3 Top Biotech Stocks to Buy in March
George Budwell, PhD|Mar 2, 2020
Acceleron Pharma, Novavax, and TG Therapeutics are all on the cusp of hitting major milestones.
